Cargando…
Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
AIMS/INTRODUCTION: Diabetes patients develop a variety of metabolic abnormalities in addition to hyperglycemia. However, details regarding change in various metabolites after comprehensive diabetes treatment remain unknown. This study aimed to identify the short‐term change in metabolome in inpatien...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668060/ https://www.ncbi.nlm.nih.gov/pubmed/34032389 http://dx.doi.org/10.1111/jdi.13600 |
_version_ | 1784614490413727744 |
---|---|
author | Taya, Naohiro Katakami, Naoto Omori, Kazuo Arakawa, Shoya Hosoe, Shigero Watanabe, Hirotaka Takahara, Mitsuyoshi Miyashita, Kazuyuki Nishizawa, Hitoshi Matsuoka, Taka‐Aki Furuno, Masahiro Bamba, Takeshi Iida, Junko Fukusaki, Eiichiro Shimomura, Iichiro |
author_facet | Taya, Naohiro Katakami, Naoto Omori, Kazuo Arakawa, Shoya Hosoe, Shigero Watanabe, Hirotaka Takahara, Mitsuyoshi Miyashita, Kazuyuki Nishizawa, Hitoshi Matsuoka, Taka‐Aki Furuno, Masahiro Bamba, Takeshi Iida, Junko Fukusaki, Eiichiro Shimomura, Iichiro |
author_sort | Taya, Naohiro |
collection | PubMed |
description | AIMS/INTRODUCTION: Diabetes patients develop a variety of metabolic abnormalities in addition to hyperglycemia. However, details regarding change in various metabolites after comprehensive diabetes treatment remain unknown. This study aimed to identify the short‐term change in metabolome in inpatients who were subject to comprehensive diabetes treatment, using gas chromatography/mass spectrometry‐based non‐target metabolomics techniques. MATERIALS AND METHODS: Participants of the present study were randomly recruited from the patients with type 2 diabetes hospitalized due to problems with glycemic control (n = 31) and volunteers without diabetes (n = 30), both of whom were aged between 20 and 75 years. A metabolomic analysis of fasting plasma samples on the 2nd (pre‐treatment) and 16th hospital (post‐treatment) day with gas chromatography/mass spectrometry using a multiple reaction monitoring mode was carried out. RESULTS: A principal component analysis showed that metabolome of fasting plasma was different between individuals with and without diabetes. The metabolome of fasting plasma in diabetes patients after treatment was different from that of pre‐treatment, as well as individuals without diabetes. Many amino acids (proline, glycine, serine, threonine, methionine, pyroglutamic acid, glutamine and lysine) were significantly increased by >10% after administering the inpatient diabetes treatment. A hierarchical clustering analysis showed that in the case of patients with markedly decreased monosaccharide levels and increased 1,5‐anhydroglucitol, the levels of amino acids increased more significantly. CONCLUSIONS: After a 2‐week comprehensive treatment, the plasma levels of various amino acids increased in conjunction with the reduction in monosaccharide levels in poorly controlled type 2 diabetes patients. |
format | Online Article Text |
id | pubmed-8668060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86680602021-12-21 Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis Taya, Naohiro Katakami, Naoto Omori, Kazuo Arakawa, Shoya Hosoe, Shigero Watanabe, Hirotaka Takahara, Mitsuyoshi Miyashita, Kazuyuki Nishizawa, Hitoshi Matsuoka, Taka‐Aki Furuno, Masahiro Bamba, Takeshi Iida, Junko Fukusaki, Eiichiro Shimomura, Iichiro J Diabetes Investig Articles AIMS/INTRODUCTION: Diabetes patients develop a variety of metabolic abnormalities in addition to hyperglycemia. However, details regarding change in various metabolites after comprehensive diabetes treatment remain unknown. This study aimed to identify the short‐term change in metabolome in inpatients who were subject to comprehensive diabetes treatment, using gas chromatography/mass spectrometry‐based non‐target metabolomics techniques. MATERIALS AND METHODS: Participants of the present study were randomly recruited from the patients with type 2 diabetes hospitalized due to problems with glycemic control (n = 31) and volunteers without diabetes (n = 30), both of whom were aged between 20 and 75 years. A metabolomic analysis of fasting plasma samples on the 2nd (pre‐treatment) and 16th hospital (post‐treatment) day with gas chromatography/mass spectrometry using a multiple reaction monitoring mode was carried out. RESULTS: A principal component analysis showed that metabolome of fasting plasma was different between individuals with and without diabetes. The metabolome of fasting plasma in diabetes patients after treatment was different from that of pre‐treatment, as well as individuals without diabetes. Many amino acids (proline, glycine, serine, threonine, methionine, pyroglutamic acid, glutamine and lysine) were significantly increased by >10% after administering the inpatient diabetes treatment. A hierarchical clustering analysis showed that in the case of patients with markedly decreased monosaccharide levels and increased 1,5‐anhydroglucitol, the levels of amino acids increased more significantly. CONCLUSIONS: After a 2‐week comprehensive treatment, the plasma levels of various amino acids increased in conjunction with the reduction in monosaccharide levels in poorly controlled type 2 diabetes patients. John Wiley and Sons Inc. 2021-07-01 2021-12 /pmc/articles/PMC8668060/ /pubmed/34032389 http://dx.doi.org/10.1111/jdi.13600 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Taya, Naohiro Katakami, Naoto Omori, Kazuo Arakawa, Shoya Hosoe, Shigero Watanabe, Hirotaka Takahara, Mitsuyoshi Miyashita, Kazuyuki Nishizawa, Hitoshi Matsuoka, Taka‐Aki Furuno, Masahiro Bamba, Takeshi Iida, Junko Fukusaki, Eiichiro Shimomura, Iichiro Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis |
title | Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis |
title_full | Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis |
title_fullStr | Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis |
title_full_unstemmed | Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis |
title_short | Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis |
title_sort | evaluation of change in metabolome caused by comprehensive diabetes treatment: a prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668060/ https://www.ncbi.nlm.nih.gov/pubmed/34032389 http://dx.doi.org/10.1111/jdi.13600 |
work_keys_str_mv | AT tayanaohiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT katakaminaoto evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT omorikazuo evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT arakawashoya evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT hosoeshigero evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT watanabehirotaka evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT takaharamitsuyoshi evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT miyashitakazuyuki evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT nishizawahitoshi evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT matsuokatakaaki evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT furunomasahiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT bambatakeshi evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT iidajunko evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT fukusakieiichiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis AT shimomuraiichiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis |